Novocure Ltd (NVCR) Stock Overview
Explore Novocure Ltd’s financial performance, market position, analyst ratings, and future outlook.
Novocure Ltd (NVCR)
Key Financials
Key Financials
Market Cap
1.9B
P/E Ratio
-12.48
EPS (TTM)
$-1.30
ROE
-0.44%
NVCR Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Novocure Ltd (NASDAQ: NVCR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Novocure Ltd's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NVCR on the NASDAQ shows an RSI of 44.75, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $10.57 for the NASDAQ listing.
Key metrics behind Novocure Ltd's NASDAQ-traded stock include a P/E ratio of -12.48 and a market capitalization of 1.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NVCR on the NASDAQ.